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Abstract
Background—Surgical resection of the ileum, cecum and proximal right colon (ICR) is
common in the management of Crohn’s disease, yet little is known about the effect of active
inflammation on the adaptive response following intestinal loss. We recently developed a surgical
model of ICR in germ-free (GF) IL-10 null mice that develop small intestinal inflammation only
when mice undergo conventionalization with normal fecal microflora (CONV) before surgical
intervention. In this study, we examined the effects of post-surgical small bowel inflammation on
adaptive growth after ICR.
Methods—8-10 week old GF 129SvEv IL-10 null mice were allocated to GF or CONV groups.
Non-operated GF and CONV mice provided baseline controls. Two weeks later GF and CONV
mice were further allocated to ICR or sham operation. Small intestine and colon were harvested 7d
after surgery for histological analysis.
Results—All mice within the gnotobiotic facility maintained GF status and did not develop small
intestinal or colonic inflammation. CONV resulted in colitis in all groups, whereas small intestinal
inflammation was only observed following ICR. Resection-induced small intestinal inflammation
in CONV mice was associated with increases in proliferation, crypt depth and villus height when
compared to GF mice after ICR. Resection-induced increases in crypt fission only occurred in
CONV mice.
Conclusion—ICR-dependent small intestinal inflammation in CONV IL-10 null mice
dramatically enhances early adaptive growth of the small intestine. Additional studies utilizing our
model may provide clinical insight leading to optimal therapies in managing IBD patients after
surgical resection.
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Inflammatory bowel disease (IBD) is a common indication for intestinal resection. It has
been estimated that upwards of 75% of patients suffering from Crohn’s disease will require
surgical intervention at some point for complications of their disease [1;2]. As many of these
patients will ultimately undergo multiple bowel resections for recurrent disease during their
lifetime, they are at risk of developing intestinal failure due to short bowel syndrome.
Clinically, the most frequent site of disease onset involves the ileum and proximal right
colon, making an ileo-cecal resection (ICR) the most common intestinal surgical procedure
in patients with Crohn’s disease [3]. Multiple studies in animal resection models have
demonstrated that the remaining intestine undergoes a process of adaptive growth to
compensate for the loss of bowel [4-8]. We have recently developed and characterized a
murine model of ICR in wild type (WT) mice to study adaptive growth response of the small
intestine and colon after this operative procedure [9]. Data from our initial characterization
of the ICR model in WT mice demonstrated marked early increases in the presence of crypt
fission after resection that was temporally associated with expansion of intestinal stem cells
(ISC) leading to sustained long-term adaptive growth. Several other published studies have
also associated the incidence of crypt fission and the expansion of ISC, notably during
development [10], following chemo-radiation [11] and in pre-malignant conditions [12].
Despite the high incidence of intestinal surgery required to treat the complications of
Crohn’s disease and the extensive research that has focused on the adaptive growth of the
small intestine, surprisingly little is known about the effect of active inflammation on the
adaptive response of the remaining small bowel after resection.
The ideal animal model to study the surgical effects of Crohn’s disease currently does not
exist as the etiology has not been well established. We therefore sought to identify a murine
model that develops reproducible, spontaneous, transmural small intestinal inflammation.
Unfortunately, to date the vast majority of IBD models predominantly develop spontaneous
colitis without small intestinal inflammation. Although a few models of ileitis have been
described [13-15], there is not one that reproducibly involves the small intestine in a healthy
animal that can undergo surgical resection. In this study we utilized the IL-10 null mouse as
it provides a well characterized, reproducible model of colitis that develops only when
exposed to microbiota and not when housed under germ free (GF) conditions [13;16-22].
The small bowel in un-operated or sham-operated IL-10 null mice does not become
inflamed following conventionalization (CONV), thus bacteria alone are insufficient to
induce small bowel inflammation in IL-10 null mice. We have recently demonstrated that
ICR results in chronic small intestinal inflammation at the anastomosis and importantly
within the distal jejunum remote from the anastomosis that persists following resection [23],
thus providing a valuable model of post-surgical small intestinal inflammation in a widely
used animal model of IBD. Importantly, IL-10 null mice maintained in a GF environment
remain disease free after resection, providing genetically matched controls to assess the
effects of small bowel inflammation on the adaptive response to ICR.
The effect of microbiota on intestinal adaptation following resection has been previously
examined. Juno et al demonstrated that a small but significant increases in both villus height
and proliferation occurred within the ileum in GF rats after massive proximal small bowel
resection when compared to CONV rats [4]. As regional differences in luminal bacteria and
adaptation following resection exist when comparing the distal versus proximal small bowel
[4], we have recently developed and characterized the effect of distal small bowel resection
(ICR) in mice [9]. In addition, we have created a surgical isolator in our gnotobiotic facility
that allows us to perform ICR and maintain GF status in mice post-operatively [24]. An
important observation from studies in GF and CONV WT C57BL6 mice was that baseline
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differences in intestinal morphology and homeostasis exist when comparing un-operated GF
and CONV animals. These differences have been described in a few animal models
including the pig where GF status has been shown to result in significantly larger villi and
smaller crypts when compared to CONV pigs [25], but have not been well characterized in
the small intestine from WT or IL-10 null mice. In our previous study in WT C57BL6 mice,
when we corrected for these baseline differences, no obvious differences in the magnitude of
small intestinal adaptive responses occurred in GF versus CONV mice after ICR. However,
bacteria-dependent up-regulation of intestinal bile acid binding protein (IBABP), and
colonic adaptation occurred in CONV mice when compared to GF following ICR. In the
current study, we sought to use our ICR model in GF and CONV IL-10 null mice to
determine the early effects of post-surgical small intestinal inflammation on adaptive growth
in the small intestine and colon. We hypothesized that bacterially-mediated intestinal
inflammation will enhance the adaptive response after ICR in this genetic model of IBD.
Methods
Animals
The University of North Carolina Institutional Animal Care and Use Committee approved
the protocol for this study (IACUC #07-229.0). Male 129SvEv IL-10 null mice that were
born and raised in the UNC gnotobiotic rodent facility were utilized for all experiments. At
eight weeks of age mice were randomly allocated to either GF or CONV groups (n = 4-12
mice/group). All mice maintained in the gnotobiotic facility were confirmed to be GF at the
conclusion of the experiment by stool viral, bacterial and fungal cultures. Additionally,
sentinel mice from the litter were kept in the same incubator after the conclusion of the
experiment as controls and were also confirmed to be GF. Mice allocated to be in the CONV
groups were transferred to our specific pathogen free (SPF) housing facility where
conventionalization was achieved by standard fecal slurry [18;19]. Mice were considered to
be CONV after 2 weeks.
Operative Procedure
Two days prior to the start of the experiment, all animals were switched from regular chow
to a sterilized liquid diet (Jevity 1cal, Isotonic Nutrition with fiber, Ross Laboratories,
Columbus, Ohio), which was changed daily throughout the study. Mice were then further
allocated to either operative or non-operative groups. The non-operative (nonop) groups
were handled identically to the operative groups with regards to feeding regimen and
bedding. The operative groups underwent either intestinal transection approximately 13cm
proximal to the ileocecal junction with primary anastomosis (sham) or an ileo-cecal
resection (ICR) as previously described [9;24]. Of note, GF surgical procedures were
performed in a customized surgical isolator in the exact same manner as utilized for CONV
animals (Figure 1). Liquid diet was provided ad libitum immediately post-operatively
through post-operative day 7, at which time the mice were sacrificed.
Tissue Harvest
All mice harvested for histology received an IP injection of bromodeoxyuridine (BrdU
120mg/kg) 90 minutes prior to sacrifice. Great care was taken to ensure we were comparing
identical segments of distal jejunum between operative and non-operative groups, with all
samples measuring 1cm. The small intestine and colon were harvested at the same location
in all mice as previously described [9]. The small intestine 1cm proximal to the anastomosis
in operative groups or 13cm proximal to the ileocecal junction in the non-operative groups
and colon 1cm distal to the anastomosis in the ICR group, and 1cm distal to the cecum in the
sham and non-operative groups were harvested. The intestine was irrigated with cold PBS
and placed into labeled cassettes for perpendicular and longitudinal sectioning and fixed
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overnight in 10% unbuffered zinc formalin (Fisher Scientific, Kalamazoo, MI). Twenty-four
hours later, the cassettes were washed with double distilled water (ddH20) and transferred to
70% alcohol for tissue processing.
Histology and Analysis of Intestinal Morphometrics
Hematoxylin and Eosin (H&E) stained histological sections were analyzed for intestinal
morphology in a blinded manner using digital images acquired with an Axio Imager
microscope (Zeiss). To determine crypt depth (CD) and villus height (VH), at least 10 well-
oriented, full-length crypt-villus units were measured and averaged for each sample. The
identification of the crypt-villus junction required that a well visualized single epithelial
layer with a central lumen was visualized in all scored crypts and villi. The end of the crypt
lumen marked the junction of the two structures as previously described [9]. BrdU
immunohistochemistry was utilized to determine proliferative index by calculating the ratio
of BrdU positive cells to total cells within at least 10 intact crypts. We have previously
defined the criteria for crypt fission (CF) as a bifurcating crypt with a bisecting fissure
creating at least two flask-shaped bases with a shared single crypt-villus junction [9]. Using
this method we determined the percent CF in ~50 well-oriented crypts from both
perpendicular and longitudinal sections per mouse.
Statistical Methods
All quantitative results are presented as mean values ± standard error of the mean (SEM). A
one-way ANOVA was initially used to compare all data in non-operated GF and CONV
IL-10 null mice to assess if baseline values differed. Since significant differences were
observed, data in sham and ICR GF or CONV IL-10 null mice were expressed as a
percentage change compared with their respective non-operated controls unless stated
otherwise. Additionally, a two-way ANOVA was performed comparing GF and CONV
operative groups to test for main effects of bacteria (GF vs. CONV) and surgery (sham vs.
ICR). Post hoc pair-wise comparisons were then used to compare data in two specific
groups. For all tests, nominal p-values were generated and less than 0.05 was considered
statistically significant. Statistical analyses were performed using SAS statistical software,
Version 9.2, SAS Institute, Inc., Cary, NC.
Results
Animals
All mice utilized in this study were healthy at the time of harvest. Although we were unable
to obtain daily weights within the gnotobiotic facility, we noted similar weight changes in
both sham operated and ICR GF and CONV mice at the time of harvest when compared to
non-operative controls. Similar excellent survival (>90 percent) occurred in both GF and
CONV mice. Groups of mice housed within the gnotobiotic facility maintained GF status
throughout the study and did not develop small intestinal or colonic inflammation.
Non-Operative Controls
After conventionalization all 129SvEv IL-10 null mice consistently developed gross and
histological evidence of colitis, as recently reported [23]. Representative sections of BrdU
immunostaining in the small intestine of non-operated GF and CONV IL-10 null mice are
presented in Figure 2. Differences in numbers of BrdU labeled cells, crypt depth and villus
height between GF and CONV mice were clearly evident in all histological sections. To
quantitate these differences, histological sections were scored for proliferative index, crypt
depth, villus height and crypt fission in non-operated GF and CONV IL-10 null mice (Table
1). These data confirmed that conventionalization results in proliferation, whereas GF mice
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have significantly taller villi when compared to CONV mice. However, similar low levels of
crypt fission were observed in both GF and CONV non-operated mice. Of note, significant
increases in colonic crypt depth also occurred following CONV (77.3±5.1 (GF) vs.
102.3±6.6 (CONV), p<0.02) in our non-operative controls. Given the differences in
morphology between GF and CONV IL-10 null non-operative controls, subsequent sham-
operated and ICR results are expressed primarily as a percentage change relative to the
corresponding non-operative data.
Operative Group
Initial evaluation of small intestinal histological sections confirmed significant inflammation
at 7d after ICR in CONV IL-10 null groups [23], while non-operated and sham-operated GF
and CONV IL-10 null mice showed little or no small intestinal inflammation. Representative
BrdU immunostained histological sections in Figure 3 demonstrate the marked inflammation
that occurs following ICR in CONV IL-10 null mice as well as the adaptive morphological
and proliferative differences that occur following ICR in CONV compared with GF mice.
Most obvious is the dramatic increase in crypt proliferation as demonstrated by the increase
in BrdU labeled cells in CONV compared to GF IL-10 null mice after ICR. Quantitative
data in Figure 4 demonstrate that operation (both sham and ICR) results in significant
increases in proliferation when compared to non-operative baseline levels in CONV mice
(p<0.05), but similar increases in GF mice did not reach statistical significance. In addition,
resection did not further increase proliferative index in either group when compared to
sham-operated groups, but significant adaptive increases in proliferation were observed in
CONV mice when compared to GF following ICR (p<0.01).
Also evident in Figure 3 is the dramatic increase in crypt depth that occurs after ICR in
CONV IL-10 null mice, which was more evident than resection-induced increases in crypt
depth in GF IL-10 null mice. These differences are notably greater when compared to sham-
operated mice as well (p<0.02). Figure 5A shows quantitative data to illustrate that both GF
and CONV IL-10 null mice demonstrate increases in crypt depth after ICR, but the
magnitude of change was significantly greater in CONV when compared to GF IL-10 null
mice (p<0.01). Of interest, ICR resulted in similar significant increases in colonic crypt
depth in both GF and CONV mice when compared to their respective non-operative
controls. Based on these observations, we focused our study on small intestinal adaptive
growth following ICR. Measurement of villus height (Figure 5B) in GF IL-10 null mice
demonstrated an overall significant reduction occurred in both sham-operated and ICR
groups compared to non-operative controls, without significant increases following ICR
when compared to sham. In contrast, CONV IL-10 null mice showed marked and significant
increases in villus height following ICR compared to sham (p<0.02). The increase in villus
height in CONV IL-10 null mice after ICR was significantly greater than in GF IL-10 null
mice after ICR (p<0.01).
Following ICR, marked increases in crypt fission associated with intestinal inflammation
were observed in all histological sections from CONV IL-10 null mice. This is in contrast to
the infrequent crypt fission typically seen in both un-operated GF IL-10 null mice and GF
IL-10 null mice after resection (Figure 6). Figure 7 compares the percent change in crypt
fission in sham-operated and ICR GF and CONV IL-10 null mice. No changes in crypt
fission were observed in GF IL-10 null mice after sham operation or ICR, whereas dramatic
increases in crypt fission were observed in CONV IL-10 null mice following ICR compared
to sham-operated CONV IL-10 null mice (p<0.02). Crypt fission in CONV IL-10 null mice
after ICR was also significantly greater than in GF IL-10 null ICR groups (p<0.01).
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In this study we sought to determine the effect of small intestinal inflammation in IL-10 null
mice on the adaptive response following the loss of the ileum, cecum and proximal colon,
similar to the clinical situation that occurs in many patients requiring surgical resection for
Crohn’s disease. We specifically utilized IL-10 null mice in this study, as the presence of
both microbiota and ICR in this model are required to initiate the small intestinal
inflammatory response [23]. This enabled the resected GF IL-10 null mice to serve as
genetically matched, non-inflamed controls. Notably, this is the first description of
postoperative small bowel adaptation in the face of ongoing small intestinal and colonic
inflammation.
When comparing the normalized adaptive response in CONV to GF mice 7d after ICR, we
demonstrated that the presence of microbiota-induced inflammation is associated with
significant increases in crypt depth, villus height, proliferation and crypt fission only in the
small intestine and not the colon after resection. These data support our hypothesis that
luminal bacteria and intestinal inflammation augment the small intestinal adaptive response.
It is noteworthy that prior studies suggest that GF status either does not influence or slightly
enhances adaptive growth responses after resection [4;9]. Thus the dramatic increase in
adaptive growth in CONV IL-10 null mice likely reflects the presence of inflammation in
CONV IL-10 null mice, although it could also reflect synergistic effects of inflammation
and microbiota. We recognize that the synergistic effect of microbiota and the lack of IL-10
may have contributed to these findings, as a modest adaptive response occurred in GF mice.
This point is supported by previous studies, including our own, which demonstrate a similar
adaptive response in GF and CONV WT mice and rats [4;24]. The observation that
inflammation after ICR dramatically enhances adaptive growth of the small intestine is
clinically relevant. This suggests that the adaptive growth effects of anti-inflammatory drugs
given to post-surgical IBD patients should be explored. Further research will be necessary to
delineate the effects of individual microbiota capable of inducing inflammation [16], which
can be accomplished utilizing our model.
Similar to other GF animal models [4;25], significant baseline differences exist between GF
and CONV IL-10 null mice. These differences highlight the importance of normalizing our
operative data to non-operative controls. Consistent with previously published reports, we
have demonstrated that villus height is notably greater in GF mice when compared to CONV
litter mates, whereas the introduction of microbiota stimulates an increase in proliferation
and crypt depth. Our findings that crypt fission is rarely observed in GF mice have not been
previously published. We were further surprised to find that ICR did not result in any
increases in crypt fission in GF IL-10 null mice. As crypt fission is closely associated with
expansion of ISC, these data indicate an important role of microbiota or inflammation in
driving this process. Our previous published data characterizing the ICR model in WT mice
demonstrates that the early expansion of ISC sustains the long-term adaptive response [9]. It
will be of great interest to assess what effect the lack of increase in crypt fission in GF IL-10
null mice will have on the long-term adaptive response.
The potential role of IL-10 in regulating adaptive growth of the small intestine is not
defined. In the current studies we included IL-10 null mice since we were testing whether
ongoing post-surgical inflammation affects adaptive growth. Future studies evaluating the
role of IL-10 and adaptive ISC expansion are of great interest. Ongoing studies to directly
compare WT and IL-10 null mice are a future direction of our laboratory. In addition, the
specific role of microbiota driving this process will have significant clinical relevance. To
address this, mono-association studies with colitogenic and non-colitogenic bacterial strains
given to IL-10 null mice maintained within our gnotobiotic facility will help determine the
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specific role of these bacteria and inflammation contributing to the adaptive effects seen in
our model.
Clinically, the robust adaptive response that occurs following intestinal resection in the
presence of active inflammation may be beneficial or detrimental. It remains a possibility
that increased inflammation and adaptation may be associated with fibrostenotic disease
[23;26]. Furthermore, the potential effect of intestinal resection on the risk and prevalence of
small intestinal adenocarcinoma in IBD patients has not been clearly defined [27;28]. As
patients with Crohn’s disease frequently require multiple intestinal resections, further studies
characterizing the regulation of ISC expansion following resection will provide important
insight into a potential role of adaptive increase in ISC and adenocarcinoma risk. These data
may impact clinical management, as the prolonged use of antibiotics, immunosuppression
and probiotics can alter luminal microbiota which, based on findings in this study, may
augment the adaptive response. In addition, delineation of the signaling pathways associated
with ISC expansion in a setting of post-surgical IBD may prove useful in both the
management of patients with intestinal failure as well as prevention of long-term surgical
complications in patients with IBD.
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Figure 1. Surgical Isolator in UNC Gnotobiotic Facility
The surgical isolator allows GF mice to undergo the exact same operative procedure as
CONV mice while remaining free of all microbiota post-operatively.
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Figure 2. Non-operative BrdU Immunohistochemistry
Representative BrdU immunostained sections from the jejunum of non-operative GF and
CONV IL-10 null mice (20x). Note the increase in BrdU labeled cells in the CONV mouse
compared to GF.
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Figure 3. Operative BrdU Immunohistochemistry
Representative BrdU immunostained sections from the jejunum of sham-operated and ICR
mice 7d following operation (20x). Note the increases in BrdU labeled cells and crypt depth
that occur in both GF and CONV mice after ICR. In addition, marked submucosal
inflammation (bracket) is only present in the CONV mouse after ICR when compared to GF
and sham-operated groups.
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Figure 4. Proliferative Index
Proliferative index is determined by the percent BrdU labeled cells per crypt in non-
operative, sham-operative and ICR CONV and GF IL-10 null mice. ** represents
statistically significant differences comparing ICR and sham-operated to non-operated mice
(p < 0.01), # represents significant difference between CONV and GF IL-10 null mice after
ICR (p < 0.01). Error bars represent ± SEM.
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A. Crypt Depth and B. Villus Height represented as the percent change compared to non-
operative controls (Table 1). * significant difference Sham: ICR (p<0.02), # significant
difference GF ICR: CONV ICR (p<0.01). Error bars represent ± SEM.
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Figure 6. Crypt Fission
Representative histological H&E sections of jejunum (20x) demonstrating normal crypt
morphology in GF IL-10 null mice compared to the observation of increased crypt fission
and inflammation in CONV IL-10 null mice after ICR. Arrows denote bifurcating crypts.
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Figure 7. Percent Change in Crypt Fission
Percent increase in crypt fission observed following sham-operation or ICR, normalized to
non-operative GF and CONV levels. * represents significant difference between CONV
Sham and ICR (p<0.02), # represents significant difference between GF and CONV IL-10
null mice 7d after ICR (p<0.01). Error bars represent ± SEM.
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Table 1
Non-operative Baseline Morphometrics
Morphometric and proliferative data from GF and CONV IL-10 null non-operative controls (n ≥ 5).
Parameter GF CONV P value
Proliferative Index (%) 9.8 ± 0.6 16.2 ± 1.1 <0.001 *
Crypt Depth (μm) 70.1 ± 4.6 81.5 ± 2.2 <0.01 *
Villus Height (μm) 387.2 ± 35.1 232.1 ± 11 <0.001 *
Crypt Fission (%) 1.2 ± 0.01 0.5 ± 0.003 NS (0.12)
P value is calculated comparing GF to CONV.
*
statistically significant.
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